Transaction in Own Shares and Total Voting Rights

Summary by AI ^BETAClose X

Fortis Frontier PLC announced the purchase of 100,000 ordinary shares at 8.6 pence per share, representing approximately 0.19% of its issued share capital, with the intention to cancel these shares. Following this transaction, the Company's total number of ordinary shares in issue will be 51,500,827, which shareholders should use as the denominator for calculating their notifiable interests under FCA rules.

Disclaimer*

Fortis Frontier PLC

16 April 2026

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

Transaction in Own Shares and Total Voting Rights

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly MyHealthChecked PLC), announces that on 15 April 2026, pursuant to the authority approved by shareholders at the Company's Annual General Meeting of 31 July 2025, the Company purchased 100,000 ordinary shares of 1.5 pence each ("Ordinary Shares") at a price of 8.6p per share, representing approximately 0.19% of the Company's issued share capital.

Total Voting Rights

The Company intends that the purchased Ordinary Shares will be cancelled as soon as practical. Following cancellation of the purchased Ordinary Shares, the Company's total number of ordinary shares in issue shall be 51,500,827 Ordinary Shares.

The above figure of 51,500,827 Ordinary Shares should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information contact:

Fortis Frontier PLC		www.fortisfrontierplc-ir.com
Adam Reynolds, Executive Chairman		via Walbrook PR

SPARK Advisory Partners Limited (NOMAD)		Tel: +44 (0)20 3368 3550
Neil Baldwin / Dillon Wall

Singer Capital Markets (Broker)		Tel: Tel: +44 (0)20 7496 3000
James Serjeant / Russell Cook / Amber Higgs

Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com
Paul McManus / Alice Woodings		Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END